P
NVO

Pitcairn’s Novo Nordisk NVO Stock Holding History

Pitcairn’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-32,113
Closed -$1.78M – 392
2025
Q3 		$1.78M Buy
32,113
+19,750
+160% +$1.16M 0.14% 130
2025
Q2 		$853K Sell
12,363
-2,102
-15% -$143K 0.06% 291
2025
Q1 		$1M Sell
14,465
-445
-3% -$36.8K 0.06% 271
2024
Q4 		$1.28M Buy
14,910
+527
+4% +$57K 0.08% 223
2024
Q3 		$1.71M Sell
14,383
-1,009
-7% -$135K 0.1% 184
2024
Q2 		$2.2M Buy
15,392
+476
+3% +$63.1K 0.13% 142
2024
Q1 		$1.92M Buy
14,916
+816
+6% +$97.1K 0.12% 162
2023
Q4 		$1.46M Buy
14,100
+5,676
+67% +$561K 0.11% 175
2023
Q3 		$766K Buy
8,424
+1,232
+17% +$109K 0.06% 260
2023
Q2 		$582K Sell
7,192
-134
-2% -$10.9K 0.05% 311
2023
Q1 		$583K Buy
7,326
+1,538
+27% +$109K 0.05% 307
2022
Q4 		$392K Buy
5,788
+120
+2% +$7.04K 0.04% 380
2022
Q3 		$282K Buy
5,668
+1,308
+30% +$70.1K 0.03% 451
2022
Q2 		$243K Buy
+4,360
New +$242K 0.03% 502
2016
Q1 		– Sell
-12,194
Closed -$354K – 487
2015
Q4 		$354K Buy
+12,194
New +$338K 0.04% 299
2015
Q3 		– Sell
-17,076
Closed -$468K – 450
2015
Q2 		$468K Sell
17,076
-430
-2% -$12.1K 0.05% 267
2015
Q1 		$467K Buy
17,506
+518
+3% +$11.9K 0.05% 272
2014
Q4 		$359K Buy
16,988
+514
+3% +$11.5K 0.04% 329
2014
Q3 		$392K Buy
16,474
+3,910
+31% +$90K 0.04% 310
2014
Q2 		$290K Buy
12,564
+786
+7% +$17.4K 0.03% 373
2014
Q1 		$269K Buy
+11,778
New +$251K 0.03% 390

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pitcairn's NVO Position: Q4 2025 in Review

Pitcairn sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 32,113 shares — an estimated $1.78M sold.

Pitcairn first reported a position in NVO in Q1 2014 and held it in 21 quarters. The position peaked at $2.2M in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Pitcairn reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 32,113 Novo Nordisk shares in Q4 2025, an estimated $1.78M.
  • Pitcairn first reported a position in Novo Nordisk in Q1 2014 and held it in 21 quarters.
  • Pitcairn's Novo Nordisk position peaked at $2.2M in Q2 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.